Nurse Practitioner, Family · Mobile, AL
NPI
1861808230
Since 2014
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1700 Spring Hill Ave Ste 100
Mobile, AL, 36604
Phone (251) 435-1200
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
261 services
Medicare patients, 2024
152
Average age 69
Drug cost, 2024
$1.5M
582 prescriptions
Company payments, 2025
$24K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher Lovell was code 91200 (standard x-ray), 70 times for 70 patients. In total Christopher Lovell billed 261 services in 10 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 91200 Standard X-ray | Office | 70 | 70 | $6.67 | $467 |
| 99214 Office E&M - Established | Office | 69 | 54 | $57.18 | $3,945 |
| 99204 Office E&M - New | Office | 39 | 39 | $79.58 | $3,104 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 31 | 24 | $9.94 | $308 |
| 49083 Digestive/Gastrointestinal | Facility | 26 | 16 | $58.96 | $1,533 |
| 99213 Office E&M - Established | Office | 16 | 16 | $41.71 | $667 |
By year: 2022 $11K for 149 services; 2023 $7,820 for 127 services; 2024 $11K for 261 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher Lovell prescribed most often to Medicare patients was Sofosbuvir-Velpatasvir (Sofosbuvir/Velpatasvir), with 50 prescriptions and refills. In total Christopher Lovell wrote 582 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sofosbuvir-Velpatasvir Sofosbuvir/Velpatasvir | 50 | 50 | 15 | $425K |
| Xifaxan Rifaximin | 48 | 48 | Under 11 | $166K |
| Pantoprazole Sodium Generic | 48 | 108 | 18 | $347 |
| Linzess Linaclotide | 41 | 59 | Under 11 | $33K |
| Vemlidy Tenofovir Alafenamide | 36 | 36 | Under 11 | $54K |
| Epclusa Sofosbuvir/Velpatasvir | 27 | 27 | Under 11 | $659K |
| Lactulose Generic | 20 | 30 | 13 | $728 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 19 | 19 | 18 | $1,326 |
| Furosemide Generic | 18 | 31 | Under 11 | $37.77 |
| Spironolactone Generic | 18 | 29 | Under 11 | $215 |
| Famotidine Generic | 18 | 54 | Under 11 | $322 |
| Dexlansoprazole Dr Dexlansoprazole | 17 | 24 | Under 11 | $3,572 |
| Suflave Peg 3350/Sod Sulf,chlr/Pot/Mag | 13 | 13 | 13 | $1,637 |
| Mycophenolate Mofetil Generic | 13 | 13 | Under 11 | $1,853 |
| Rezdiffra Resmetirom | 12 | 12 | Under 11 | $47K |
Brand drugs: 275 claims; generic drugs: 307 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher Lovell $24K ($24K in general payments such as food, travel and fees) from 18 companies. The largest payer was Madrigal Pharmaceuticals with $9,032.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 33 | $9,032 |
| Abbvie Inc. ABBV | 58 | $7,465 |
| Gilead Sciences, Inc. GILD | 32 | $5,912 |
| Novo Nordisk Inc NVO | 5 | $201 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 8 | $199 |
| Intercept Pharmaceuticals, Inc. | 4 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $107 |
| Phathom Pharmaceuticals, Inc. PHAT | 7 | $71.51 |
| Janssen Biotech, Inc. JNJ | 3 | $54.59 |
| Genzyme Corporation SNY | 2 | $53.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.